Abstract
(Reg Anesth Pain Med. 2015;40:344–348) The most common side effect of subarachnoid (SA) anesthesia for cesarean delivery (CD) is hypotension, and the use of serotonin receptor-blocking drugs has been suggested as a possible treatment for this. One receptor antagonist that has been proposed for this use in both obstetric and nonobstetric settings is ondansetron. However, current studies regarding the use of ondansetron are either underpowered or have reported conflicting results. The purpose of this study was to determine how useful ondansetron actually is in the prevention of hypotension, particularly when it is administered intravenously and prophylactically to women undergoing elective CD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
